期刊文献+

参麦开肺散对降低肺纤维化小鼠胶原生成的影响 被引量:5

Effects of Shenmai Kaifei Powder on Reduction of Collagenation in Mice with Pulmonary Fibrosis
下载PDF
导出
摘要 目的:利用博莱霉素诱导的肺纤维化小鼠模型研究参麦开肺散对胶原生成的影响。方法:将6~8周龄C57BL/6小鼠单次气管灌注浓度为2.5 mg·kg-1的博莱霉素,建立肺纤维化模型;24只小鼠随机平均分为预防组和治疗组,两组分别包括对照组、模型组和药物组。从小鼠肺组织病理切片、肺组织胶原含量、胶原基因表达量、细胞外基质基因表达量等4个方面研究参麦开肺散在缓解肺纤维化过程中对胶原生成的影响。结果:无论是预防组还是治疗组,对照组中小鼠肺组织均无明显病理变化,模型组小鼠肺泡结构破坏,炎症细胞浸润,并有大量以胶原为主的细胞外基质沉积,表现出了严重的纤维化病变。经过药物治疗,小鼠肺泡结构接近正常,且细胞外基质沉积现象明显缓解;实时定量PCR结果显示,模型组小鼠肺组织中胶原基因Col1a1、Col1a2、Col3a1表达量显著升高,喂食药物后,胶原基因表达量大幅度下调。此外,模型组中细胞外基质基因如Ctgf、Fn1、Sparc、Tgf-β1的表达量相对于对照组均有所升高,而喂食药物之后其表达量均有所下调。结论:参麦开肺散通过降低相关纤维化基因如Ctgf、Fn1、Sparc、Tgf-β1的表达而有效减少胶原的生成,缓解纤维化进程。 Objective:To study the effects of Shenmai Kaifei Powder on collagenation in bleomycin-induced mice models with pulmonary ifbrosis.Methods:6~8-week-old C57BL/6 mice were given intratracheal instillation of bleomycin with the concentration of 2.5 mg·kg-1 to induce models with pulmonary ifbrosis;24 mice were randomly divided into the prevention group and the treatment group,respectively including the control group,the model group and the drug group.Studied the effects of Shenmai Kaifei Powder on collagenation in relieving pulmonary fibrosis from 4 aspects:pathological section of the mouse lung tissue,collagen content of the lung tissue,collagen gene expression and extracellular matrix gene expression.Results:No matter in the the prevention group or the treatment group,the lung tissue of the control group showed no signiifcant pathological changes,while in the model group,there were damage of alveolar structure,inflammatory cell infiltration and a large amount of extracellular matrix deposition composed mainly of collagen,showing a severe fibrosis.After treatment,the mouse alveolar structure recovered to normal and extracellular matrix deposition was alleviated;the results of real-time quantitative PCR showed a signiifcant increase of Col1a1,Col1a2 and Col3a1 expressions in the lung tissue of the model group.After feeding drugs,collagen gene expression significantly decreased.In addition,the expressions of extracellular matrix genes such as Ctgf,Fn1,Sparc and Tgf- β1in the model group increased compared with those of the control group,while the expressions reduced after giving drugs. Conclusion:Shenmai Kaifei Powder can effectively reduce the formation of collagen by reducing the expressions of related ifbrosis genes such as Ctgf,Fn1,Sparc and Tgf-β1,slowing the process of ifbrosis.
出处 《风湿病与关节炎》 2014年第6期19-22,38,共5页 Rheumatism and Arthritis
基金 国家自然科学基金(81270120) 国家国际科技合作专项(2013DFA30870)
关键词 肺纤维化 参麦开肺散 胶原 细胞外基质 纤维化基因 小鼠 pulmonary ifbrosis Shenmai Kaifei Powder collagen extracellular matrix ifbrosis gene mice
  • 相关文献

参考文献13

  • 1King-TE Jr, Schwarz MI,Brown K,et al.Idiopathic pulmonary fibrosis:relationship between histopath- ologic features and mortality [ J ] .Am J Respir Crit Care Med,2001,164 ( 6 ) :1025-1032.
  • 2Raghu G,Weycker D,Edelsberg J,et al.Incidence and prevalence of idiopathic pulmonary fibrosis [ J ].Am J Respir Crit Care Med,2006,174 ( 7 ) :810-816.
  • 3Wang JC,Lai S,Guo X,et al.Attenuation of fibrosis in vitro and in vivo with SPARC siRNA [ J ] .Arthritis Res Ther,2010,12 ( 2 ) :R60.
  • 4Kim DS,Collard HR,King TE Jr.Classificat and natural history of the idiopathic intersti pneumonias [J] .Proc Am Thorac Soc,200 1on tial 6,3(4) :285-292.
  • 5Raghu G,Collard HR,Egan JJ,et al.An official ATS/ ERS/JRS/ALAT statement:idiopathic pulmonary fibrosis:evidence-based guidelines for diagnosis and management [ J ] .Am J Respir Crit Care Med,2011,183 ( 6 ) :788-824.
  • 6Clark JG,Kostal KM,Marino BA.Bleomycin-induced pulmonary fibrosis in hamsters:an alveolar marcrophage product increases fibroblast prostaglandin E2 and cyclic adenosine mono-phosphate and suppresses fibroblastproliferation and collagen production [ J ] .J Clin Invest,1983,72 ( 6 ) :2082-2091.
  • 7Lu Z,Song Y, Xue D,et al.Effect of salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cellsE J ]. J Ethnopharmacol,2010,132 ( 2 ) :384-392.
  • 8Lu ZG,Xu LM.Salvianolic acid B inhibits ERK and p38 MAPK signaling in TGF-β1-stimulated human hepatic stellate cell line ( LX-2 ) via distinct pathways [ J ] . Evid Based Complement Altemat Med,2012,9 ( 6 ) :11.
  • 9Derk CT, Jimenez SA.Systemic sclerosis:current views of its pathogenesis [ J ] .Autoimmun Rev,2003,2(4) :181-191.
  • 10Grotendorst GR.Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts [ J]. Cytokine Growth Factor Rev,1997,8 ( 3 ) : 171-179.

同被引文献98

  • 1吴东海.系统性硬化病诊治指南(草案)[J].中华风湿病学杂志,2004,8(6):377-379. 被引量:26
  • 2吴以岭.络病病机特点与病机变化[J].疑难病杂志,2004,3(5):282-284. 被引量:130
  • 3于慧敏,张凤山.系统性硬化症发病机制研究进展[J].中华风湿病学杂志,2005,9(6):362-365. 被引量:13
  • 4吴素清,黄荔红,喻荔琳,黄春霞.静脉输液不良反应处理情景模拟演练的设计及效果评价[J].解放军护理杂志,2006,23(7):8-10. 被引量:19
  • 5钟南山,刘文宁.呼吸病学[M].北京:人民卫生出版社,2012:526-527.
  • 6Iudici M, Cuomo G, Vettori S, et al. Low-dose pulse cyclophosphamide in interstitial lung disease associated with systemic sclerosis (SSc- ILD) : efficacy of maintenance immunosuppression in responders and non-responders [ J ]. Semin Arthritis Rheum, 2015,44 ( 4 ) : 437-444.
  • 7Masi AT, Rodnan GP, Medsgcr TA, et al. Preliminary criteria for the classification of systemic (sclcroderma) [ J ]. Arthritis Rheum, 1980,23 (5) :581-590.
  • 8中华人民共和国卫生部.中药新药临床指导原则[Z],1995:197.
  • 9Vaz CP, Almeida I, Guedes M, et al. Autologous stem cell transplanta- tion in a patient with severe systemic sclerosis [ J]. Acta Reumatol Port, 2014,39 ( 3 ) :262-264.
  • 10Cheresh P, Kim S J, Tulasiram S, et al brosis[J]. Biochimicaet Biophysica Disease, 2013,1832 ( 7 ) : 1028-1040.

引证文献5

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部